Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a post on X:
“ESTRO-EANO guideline on target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma – Radiotherapy and Oncology.
IDH-mutant grade 2 and 3 diffuse gliomas have a long overall survival.
Clinical management balances disease control and preserving neurological function.
Recommendations for radiation target volumes and treatment dose.”
Authors: Brigitta G. Baumert, Jaap P. M. Jaspers, Vera C. Keil, Norbert Galldiks, Ewa Izycka-Swieszewska, Beate Timmermann, Anca L. Grosu, Giuseppe Minniti, Umberto Ricardi, Frédéric Dhermain, Damien C. Weber, Martin van den Bent, Roberta Rudà, Maximilian Niyazi, Sara Erridge
More posts featuring Elisabetta Bonzano.